Related content

Bisphosphonates for osteoporosis prevention and treatment

By Jarvis Courtney   Morin Anna   Lynch Ann  

Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 1, 2005-03 ,pp. : 3-18

Humana Press, Inc

Access to resources Recommend Favorite

Injectable bisphosphonates for the treatment of osteoporosis

By Reginster Jean-Yves   Burlet Nansa   Close Pierre   Bruyere Olivier  

Women's Health, Vol. 3, Iss. 6, 2007-11 ,pp. : 719-723

Future Medicine

Access to resources Recommend Favorite

Long-term use of bisphosphonates in osteoporosis

By Rizzoli René  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 309-315

Future Medicine

Access to resources Recommend Favorite

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

By Rizzoli R.   Åkesson K.   Bouxsein M.   Kanis J.   Napoli N.   Papapoulos S.   Reginster J.-Y.   Cooper C.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 373-390

Springer Publishing Company

Access to resources Recommend Favorite

Continuous Increase in Erythropoietic Activity despite the Improvement in Bone Mineral Density by Zoledronic Acid in Patients with Thalassemia Intermedia-Induced Osteoporosis

By  

Acta Haematologica, Vol. 119, Iss. 1, 2008-02 ,pp. : 40-44

Karger

Access to resources Recommend Favorite